Page 2 - Infobionic Inc News Today

/PRNewswire/ -- The "Chronic Disease Management: Therapeutics, Device Technologies and Global Markets" report has been added to ResearchAndMarkets.coms...

Dublin, April 20, 2022 (GLOBE NEWSWIRE) -- The "Chronic Disease Management: Therapeutics, Device Technologies and Global Markets" report has been added...

09.03.2022 - Cash proceeds of $60.8 million from exits during 2021 Repurchases of 4.5 million common shares during 2021 Initiates evaluation of strategic options Conference call and webcast on March 9, 2022 at 5 p.m. ET RADNOR, Pa., March 09, 2022 (GLOBE ...

Cash proceeds of $60.8 million from exits during 2021 Repurchases of 4.5 million common shares during 2021 Initiates evaluation of strategic options ...

The increasing presence of data-driven solutions in the healthcare and life sciences sector is apparent from the rise in numbers of patents and…

In Health Discovery Corp. v. Intel Corp., Judge Alan Albright granted, in part, Intel's motion to dismiss infringement claims of AI machine-learning patents on § 101 grounds.

After reflecting upon the events of the past twelve months, Patent Docs presents its 15th annual list of top patent stories. For 2021, we identified nine stories that were covered on...

The increasing presence of data-driven solutions in the healthcare and life sciences sector is apparent from the rise in numbers of patents and patent applications. The number of...

Software-based medical devices that focus on "data processing" can be patented. However, a patent practitioner should exercise care when drafting such claims.

While there may have been no public tricks or treats from the Federal Circuit last week, the Court still managed to issue a range of precedential and non-precedential decisions.